Early Identification and Treatment of Developmental Trochlear Femoral Dysplasia
Recruiting
N/A
Interventional Study
TROCLEAR DYSPLASIA
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 0 Months – 6 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Joaquín Moya-Angeler Pérez-Mateos · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Title
Early identification and treatment of developmental trochlear femoral dysplasia.
Objectives
To identify developmental trochlear femoral dysplasia (DTFD) in the newborn early after birth by ultrasound and evaluate the effect of its treatment with a modificed Pavlik harness.
Study design
Randomized triple-blind clinical trial.
Study population
Newborns with risk factors for the developm…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy term and preterm newborns \> 35 weeks
* Breech presentation at birth.
Exclusion Criteria:
* Infant cerebral palsy,
* Developmental disorders
* Chromosomal diseases.
Contacts